Form 4 for ECOR electroCore, Inc.
Accepted 2023-08-04 00:00:00 ET · period of report 2023-08-02 · accession 0001193805-23-001088 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2023-08-04 | 2023-08-02 | ECOR | Goldstein Julie Ann | Dir | A - Grant | $4.35 | +34.0K | 69.7K | +95% | +$147.9K |
| D | 2023-08-04 | 2023-08-02 | ECOR | Goldstein Julie Ann | Dir | P - Purchase | $0.06 | +17.0K | 17.0K | New | +$1,020 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2023-08-02 | A | A | 33,994 | $4.35 | 69,679 | D | — | — | (F1) On August 2, 2023, pursuant to a private placement offering by the Issuer, the Reporting Person acquired 33,994 Units, each Unit consisting of (i) one share of the Issuer's Common Stock and (ii) one Warrant to purchase one-half share of the Issuer's Common Stock. The combined purchase price in the Offering was $4.4125 per Unit, inclusive of $4.35 per share of Common Stock and $0.0625 per Warrant. Each Warrant entitles the holder thereof to purchase one half of a share of Common Stock, is exercisable beginning six months from the date of issuance at an exercise price of $4.35 per share, and expires five years from the initial exercise date. (F3) Includes 1,665 shares held in NeuroSpine Ventures; an entity in which the Reporting Person has no voting or dispositive power over the shares. Accordingly, the Reporting Person disclaims beneficial ownership of these securities except to the extent of her pecuniary interest therein, and the inclusion of these securities in this report shall not be deemed an admission of beneficial ownership of all of the reported securities for purposes of Section 16 or for any other purpose. (F2) Includes 4,444 shares that have vested pursuant to previously issued Deferred Stock Units; 5,556 of shares will vest monthly through March 15, 2025. All such vested and unvested shares were previously reported on Form 4 filings at the time of grant. |
| 2 | Derivative | Warrants to Purchase Common Stock | 2023-08-02 | P | A | 16,997 | $0.06 | 16,997 | D | $4.35 · 2024-02-02 to 2029-02-02 | 16,997 Common Stock |